Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes

被引：76

作者：

Sattar, N ^{[1
]}

Perera, M

Small, M

Lumsden, MA

机构：

[1] Glasgow Royal Infirm Univ NHS Trust, Clin Biochem, Glasgow G4 0SF, Lanark, Scotland

[2] Gartnavel Gen Hosp, Ctr Diabet, Glasgow G4 0SF, Lanark, Scotland

[3] Queen Mothers Hosp, Dept Obstet & Gynaecol, Glasgow G4 0SF, Lanark, Scotland

来源：

LANCET | 1999年 / 354卷 / 9177期

关键词：

D O I：

10.1016/S0140-6736(99)02079-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

C-reactive protein concentrations as a marker of inflammation predicts vascular risk and is raised in type-2 diabetes. In a 6-month double-blind placebo controlled trial, a combination of transdermal oestradiol 80 mu g with continuous oral norethisterone 1 mg significantly reduced C-reactive protein concentrations in postmenopausal women with type-2 diabetes.

引用

页码：487 / 488

页数：2

共 5 条

[1] EFFECT OF ESTROGEN REPLACEMENT ON BONE METABOLISM AND CYTOKINES IN SURGICAL MENOPAUSE [J].

CANTATORE, FP ;

LOVERRO, G ;

INGROSSO, AM ;

LACANNA, R ;

SASSANELLI, E ;

SELVAGGI, L ;

CARROZZO, M .

CLINICAL RHEUMATOLOGY, 1995, 14 (02) :157-160

[2] POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY AND CARDIOVASCULAR RISK REDUCTION - A REVIEW [J].

KAFONEK, SD .

DRUGS, 1994, 47 :16-24

[3] Statins and C-reactive protein [J].

Kluft, C ;

de Maat, MPM ;

Leuven, JAG ;

van Loon, BJP ;

Mohrschladt, MF .

LANCET, 1999, 353 (9160) :1274-1274

[4] Inflammation, atherosclerosis, and ischemic events - Exploring the hidden side of the moon [J].

Maseri, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (14) :1014-1016

[5]

SITTERI PK, 1977, ANN NY ACAD SCI, V286, P384

← 1 →